{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-111319","form_type":"8-K","ticker":"LCTX","cik":"0000876343","company_name":"Lineage Cell Therapeutics, Inc.","filed_at":"2025-08-26T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.544235+00:00","generated_at":"2026-05-17T10:06:55.116974+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Lineage Cell Therapeutics enters collaboration with WDI for hearing loss program; up to $12M funding","bullets":["Multi-year research collaboration with William Demant Invest 2 Aps to advance ReSonance (ANPI) preclinical program for hearing loss.","WDI will fund up to $12 million in research costs over the approximate three-year term.","Objective: complete preclinical phase to achieve readiness for potential human clinical trials.","IP: jointly owned project results; each party retains background IP and platform technology.","If a party abandons, the continuing party may purchase the abandoning party's IP interest in the project."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-111319","json":"https://secwatch.observer/filing/0000950170-25-111319.json","markdown":"https://secwatch.observer/filing/0000950170-25-111319.md","text":"https://secwatch.observer/filing/0000950170-25-111319.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/876343/000095017025111319/0000950170-25-111319-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/876343/000095017025111319/lctx-20250826.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T10:06:55.116974+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}